C. Turkes Et Al. , "In vitro inhibitory effects of palonosetron hydrochloride, bevacizumab and cyclophosphamide on purified paraoxonase-I (hPON1) from human serum," ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY , vol.42, pp.252-257, 2016
Turkes, C. Et Al. 2016. In vitro inhibitory effects of palonosetron hydrochloride, bevacizumab and cyclophosphamide on purified paraoxonase-I (hPON1) from human serum. ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY , vol.42 , 252-257.
Turkes, C., SÖYÜT, H., & Beydemir, S., (2016). In vitro inhibitory effects of palonosetron hydrochloride, bevacizumab and cyclophosphamide on purified paraoxonase-I (hPON1) from human serum. ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY , vol.42, 252-257.
Turkes, Cuneyt, HAKAN SÖYÜT, And Sukru Beydemir. "In vitro inhibitory effects of palonosetron hydrochloride, bevacizumab and cyclophosphamide on purified paraoxonase-I (hPON1) from human serum," ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY , vol.42, 252-257, 2016
Turkes, Cuneyt Et Al. "In vitro inhibitory effects of palonosetron hydrochloride, bevacizumab and cyclophosphamide on purified paraoxonase-I (hPON1) from human serum." ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY , vol.42, pp.252-257, 2016
Turkes, C. SÖYÜT, H. And Beydemir, S. (2016) . "In vitro inhibitory effects of palonosetron hydrochloride, bevacizumab and cyclophosphamide on purified paraoxonase-I (hPON1) from human serum." ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY , vol.42, pp.252-257.
@article{article, author={Cuneyt Turkes Et Al. }, title={In vitro inhibitory effects of palonosetron hydrochloride, bevacizumab and cyclophosphamide on purified paraoxonase-I (hPON1) from human serum}, journal={ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY}, year=2016, pages={252-257} }